Most poliovirus (PV) strains, such as PV type 1/Mahoney, cannot infect
the mouse central nervous system. We previously identified two determ
inants of mouse adaptation of PV type 1/Mahoney at positions 22 and 31
of the viral capsid proteins VP1 and VP2, respectively (T. Couderc, J
. Hogle, H. Le Blay, F. Horaud, and B. Blondel, J. Virol. 67:3808-3817
, 1993). These residues are located on the interior surface of the cap
sid. In an attempt to understand the molecular mechanisms of adaptatio
n of PV to mice, we investigated the effects of these tno determinants
on the viral multiplication cycle in a human cell line. Both determin
ants enhanced receptor-mediated conformational changes leading to alte
red particles of 135S, one of the first steps of uncoating, and viral
internalization. Furthermore, the residue at position 22 of VP1 appear
s to facilitate RNA release. These results strongly suggest that these
determinants could also facilitate conformational changes mediated by
the PV murine receptor and internalization in the mouse nerve cell, t
hus allowing PV to overcome its host range restriction. Moreover, both
mouse adaptation determinants are responsible for defects in the asse
mbly of virions in human cells and affect the thermostability of the v
iral particles. Thus, these mouse adaptation determinants appear to co
ntrol the balance between the viral capsid plasticity needed for the c
onformational changes in the early steps of infection and the structur
al requirements which are involved in the assembly and the stability o
f virions.